Clinical significance of the BRAF(V600E) mutation in PTC and its effect on radioiodine therapy

The goal of this study was to explore the relationship of the BRAF(V600E) mutation with clinicopathologic factors and evaluate the effect of radioactive iodine (RAI) therapy in a large group of intermediate- and high-risk papillary thyroid cancer (PTC) patients with the BRAF(V600E) mutation and with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Guoquan, Deng, Yuying, Pan, Liqin, Ouyang, Wei, Feng, Huijuan, Wu, Juqing, Chen, Pan, Wang, Jing, Chen, Yanying, Luo, Jiaxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547306/
https://www.ncbi.nlm.nih.gov/pubmed/31071680
http://dx.doi.org/10.1530/EC-19-0045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547306/
https://www.ncbi.nlm.nih.gov/pubmed/31071680
http://dx.doi.org/10.1530/EC-19-0045

Ejemplares similares